Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir

Xiangrui Jiang(Chinese Academy of Sciences), Yechun Xu(Shanghai Institute of Materia Medica)
Nature Communications
October 13, 2023
10.1038/s41467-023-42102-y
Cited by 103

Related Papers

No related papers found

Powered by citation graph analysis